Performance evaluation of the BD phoenix automated microbiology system in meropenem susceptibility testing of clinical Pseudomonas aeruginosa isolates
Bayramoglu, G.; Acuner, I.C.; Sinirtas, M.; Gedikoglu, S.; Durupinar, B.
Saudi Medical Journal 27(12): 1921-1923
2006
ISSN/ISBN: 0379-5284 PMID: 17143380 Document Number: 604369
Document emailed within 1 workday
Related Documents
Endimiani, A.; Luzzaro, F.; Tamborini, A.; Lombardi, G.; Elia, V.; Belloni, R.; Toniolo, A. 2002: Identification and antimicrobial susceptibility testing of clinical isolates of nonfermenting gram-negative bacteria by the Phoenix Automated Microbiology System New Microbiologica 25(3): 323-329Idris, S.Nur.Atiqah.; Desa, M.Nasir.Mohd.; Aziz, M.Nazri.; Taib, N.Mohd. 2012: Antimicrobial susceptibility pattern and distribution of exoU and exoS in clinical isolates of Pseudomonas aeruginosa at a Malaysian hospital Southeast Asian Journal of Tropical Medicine and Public Health 43(1): 116-123
Sader; Cerbara; Luz; Hashimoto 1999: Evaluation of the Cephalosporins, Cefepime, Cefpirome and Ceftazidime, against Clinical Isolates of Imipenem-Resistant Pseudomonas aeruginosa Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 3(6): 231-237
Subramaniam, L.; Shriniwas 1986: Correlation of pyocyanine & pyocin production by clinical isolates of Pseudomonas aeruginosa Indian Journal of Medical Research 84: 255-259
Igari, J. 1990: Susceptibilities of clinical bacterial isolates to antimicrobial agents. A study mainly focused on imipenem. Reported by the Research Group for Testing Imipenem Susceptibility on Clinical Isolates Japanese Journal of Antibiotics 43(11): 1956-2002
Mereuţă, A.I.; Tuchiluş, C.; Bădescu, A.C.; Iancu, L.ţa.S. 2011: Metallo-beta-lactamase-mediated resistance among carbapenem-resistant Pseudomonas aeruginosa clinical isolates Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 115(4): 1208-1213
Gould, S.W.J.; Fielder, M.D.; Kelly, A.F.; El Sankary, W.; Naughton, D.P. 2009: Antimicrobial pomegranate rind extracts: enhancement by Cu(II) and vitamin C combinations against clinical isolates of Pseudomonas aeruginosa British Journal of Biomedical Science 66(3): 129-132
Tasaka, K.; Ishida, A.; Chinzei, T. 2002: Antimicrobial activity of carbapenems and the combined effect with aminoglycoside against recent clinical isolates of Pseudomonas aeruginosa Japanese Journal of Antibiotics 55(2): 181-186
Naenna, P.; Noisumdaeng, P.; Pongpech, P.; Tribuddharat, C. 2010: Detection of outer membrane porin protein, an imipenem influx channel, in Pseudomonas aeruginosa clinical isolates Southeast Asian Journal of Tropical Medicine and Public Health 41(3): 614-624
Shigeta, S.; Goto, S.; Ishida, N. 1971: Pseudomonas aeruginosa infection in the hospital environment. 2. Pigment production and serotype of Pseudomonas aeruginosa isolated from clinical specimens Rinsho Byori. Japanese Journal of Clinical Pathology 19(1): 77-80
DeMatteo, C.S.; Hammer, M.C.; Baltch, A.L.; Smith, R.P.; Sutphen, N.T.; Michelsen, P.B. 1981: Susceptibility of Pseudomonas aeruginosa to serum bactericidal activity. a comparison of three methods with clinical correlations Journal of Laboratory and Clinical Medicine 98(4): 511-518
García-Rodríguez, J.A.; García Sánchez, J.E.; Muñoz Bellido, J.L.; García Sánchez, E.; García García, M.I. 1991: In-vitro activity of meropenem, a new carbapenem, against imipenem-resistant Pseudomonas aeruginosa and Xanthomonas maltophilia Journal of ChemoTherapy 3(3): 143-146
Işeri, L.; Bayraktar, M.Refik. 2008: Changes in the rates of antimicrobial resistance among clinical isolates of Pseudomonas aeruginosa between 2002 and 2004 in a tertiary-care teaching hospital in Turkey New Microbiologica 31(3): 351-355
Delisle, F.; Lesage, D.; Barakett, V.; Richard, G.; Petit, J.C. 1996: In vitro study of the bacteriostatic and bactericidal activity of meropenem against strains of Pseudomonas aeruginosa multiresistant to antibiotics Pathologie-Biologie 44(5): 337-340
Drenjancević, D.; Vranes, J.; Bedenić, B.; Sakić-Zdravcević, K. 2007: In vitro effect of subinhibitory concentrations of ceftazidime and meropenem on the serum sensitivity of Pseudomonas aeruginosa strains Collegium Antropologicum 31(1): 221-225
Grollier, G.; Burucoa, C.; Bonnin, M.; de Rautlin de La Roy, Y. 1992: Identification and susceptibility testing for obligate anaerobic bacteria using a semi-automated APi ATB plus system Annales de Biologie Clinique 50(6-7): 393-397
Lu, J-Jih.; Lee, S-Yi.; Chiueh, T-Shi. 2004: In vitro antifungal susceptibility testing of Candida blood isolates and evaluation of the E-test method Journal of Microbiology Immunology and Infection 37(6): 335-342
Zhao, M.; Zhou, Z.-t. 2006: Antifungal susceptibility testing of commensal and pathogenic clinical isolates of oral Candida Shanghai Kou Qiang Yi Xue 15(2): 218-220
Dejsirilert, S.; Suankratay, C.; Trakulsomboon, S.; Thongmali, O.; Sawanpanyalert, P.; Aswapokee, N.; Tantisiriwat, W. 2009: National Antimicrobial Resistance Surveillance, Thailand (NARST) data among clinical isolates of Pseudomonas aeruginosa in Thailand from 2000 to 2005 Journal of the Medical Association of Thailand 92 Suppl. 4: S68-S75
Matinca, D.; Vancea, D.; Boboş, C.; Serban, O. 2004: Antibiotic resistance of some Pseudomonas aeruginosa isolates Bacteriologia Virusologia Parazitologia Epidemiologia 48(2-3): 157-161